General Information of Drug (ID: DMZW9HA)

Drug Name
Olsalazine Drug Info
Synonyms Azodisal; Dipentum; Olsalazine sodium; Di-mesalazine
Indication
Disease Entry ICD 11 Status REF
Ulcerative colitis DD71 Approved [1]
Cross-matching ID
PubChem CID
22419
ChEBI ID
CHEBI:7770
CAS Number
CAS 15722-48-2
TTD Drug ID
DMZW9HA
ACDINA Drug ID
D00487

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
EPICATECHIN DMN0EMP Duchenne dystrophy 8C70 Phase 1/2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Oxidoreductase unspecific (OR) TTPZ7AG NOUNIPROTAC Modulator [2]

References

1 ClinicalTrials.gov (NCT00004288) Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis. U.S. National Institutes of Health.
2 Reaction mechanism of azoreductases suggests convergent evolution with quinone oxidoreductases. Protein Cell. 2010 Aug;1(8):780-90.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)